Evonik launches new line of RESOMER® Composite to enhance the performance of bone fixation devices
Evonik, a global leader for advanced biomaterials and application technology solutions for bioresorbable implants, today announced the launch of its first product grade from a new line of RESOMER® Composite polymers.
Evonik to transform its Medical Devices Project House into a competence center dedicated to collaborative R&D
Over the past four years, Evonik has built up extensive competencies in the area of orthopedic surgery in its Medical Devices Project House in the United States. The project house in Birmingham (Alabama), which ran for a limited period of time, will be turned into a permanent competence center as of April 1, 2018.
Evonik launches new sterile and ultra-low-metal content bioresorbable polymers
Evonik, a global leader in biomaterials, is expanding its RESOMER® portfolio of bioresorbable polymers for controlled-release parenteral drug formulations. It now offers RESOMER® Zero and RESOMER® Sterile versions of both its standard RESOMER® polymers and RESOMER® Select customized solutions.
Evonik Industries and Eli Lilly and Company (Lilly) today announced the renewal of a long-term agreement under which Evonik will supply active pharmaceutical ingredients (APIs) and intermediates for use in key Lilly human and veterinary drug products.
Evonik introduces Risumalt® a low-calorie, sugar-free sweetener solution with significant consumer and manufacturing benefits at the Food Ingredients (FI) Asia trade show being held in Bangkok, Thailand from September 13 to 15, 2017.
Evonik presents liposomal drug delivery systems and celebrates 30th anniversary of RESOMER® at CPhl worldwide in Barcelona
Evonik will present the products and services of its new business segment Transferra Nanosciences, a leading provider of liposomal drug delivery systems, for the first time at CPhI this year (Barcelona, October 4 - 6).